In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

BioSpecifics Technologies Corp. Trade Record

NASDAQ:BSTC BioSpecifics Technologies Corp stock gains 9.33% Exit Aug 23, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart BSTC Aug 8, 2018, priceSeries
About BioSpecifics Technologies Corp

BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase clostridium histolyticum for multiple indications in the United States. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX brand in Canada and Australia, as well as under XIAPEX brand name in Europe. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, and plantar fibromatosis, as well as for the treatment of human lipoma and uterine fibroids. The company is also involved in the development of other clinical indications for which collagenase injection has been tested, such as keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy. It has a development and license agreement with Endo Global Ventures. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Lynbrook, New York.

Trade Information
Trade Type
LONG
ReliabilityScore™
75.88
Entry Date
Aug 8, 2018
Entry Price
46.66
Sell Date
Aug 23, 2018
Sell Price
51.01
Net Gain
9.33%
Hold Time
11 Trading Days